ORF_ID	Contig	Start	Stop	Orientation	Cut_Off	Pass_Bitscore	Best_Hit_Bitscore	Best_Hit_ARO	Best_Identities	ARO	Model_type	SNPs_in_Best_Hit_ARO	Other_SNPs	Drug Class	Resistance Mechanism	AMR Gene Family	Predicted_DNA	Predicted_Protein	CARD_Protein_Sequence	Percentage Length of Reference Sequence	ID	Model_ID	Nudged	Note	Hit_Start	Hit_End	Antibiotic
BGC0000249.1|Nogalamycin_1 # 2 # 382 # -1 # ID=1_1;partial=10;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.745	BGC0000249.1|Nogalamycin_1 	2	382	-	Loose	470	35.8094	gadW	27.37	3003838	protein homolog model	n/a	n/a	macrolide antibiotic; fluoroquinolone antibiotic; penam	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGACGTTCCACCCGAGTGCCGCCGCCTGTCAGCAGGCCGGGTTCCGGGCCTGCAAGCGCTGCCGCCCCGACACCAGCCCCGGCTCCCCGGAGTGGAACCGGCGCGCCGACCTGGTCGCCCGCGCCATGCGGCTGATCGCCGACGGCGTCGTGGACCGCGAGGGCGTGCCCGGACTCGCCGCCCGGCTCGGCTACAGCACCCGCCAGGTGGAACGGCAACTCCTCGCCGAACTGGGCGCCGGACCCCTCGCGCTCGCCCGCGCCCAGCGCGCCCAGACCGCGCGGATGCTCATCGAGACCACCGCGCTGCCCATGGCCGACATCGCGTTCGCGGCCGGCTTCTCCTCCATACGCGGCTTCAACGACACCGTCCGCGAGATC	MTFHPSAAACQQAGFRACKRCRPDTSPGSPEWNRRADLVARAMRLIADGVVDREGVPGLAARLGYSTRQVERQLLAELGAGPLALARAQRAQTARMLIETTALPMADIAFAAGFSSIRGFNDTVREI	MAHVCSVILVRRSFDIHHEQQKISLHNESILLLDKNLADDFAFCSLDTRRLDIEELTVCHYLQNIRQLPRNLGLHSKDRLLINQSPPIQLVTAIFDSFNDPRVNSPILSKMLYLSCLSMFSHKKELIPLLFNSISTVSGKVERLISFDIAKRWYLRDIAERMYTSESLIKKKLQDENTCFSKILLASRMSMARRLLELRQIPLHTIAEKCGYSSTSYFINTFRQYYGVTPHQFSQHSPGTFS	52.48	gnl|BL_ORD_ID|2082|hsp_num:0	2324			390	672	erythromycin; cloxacillin; oxacillin; norfloxacin
BGC0000249.1|Nogalamycin_2 # 616 # 1470 # -1 # ID=1_2;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.752	BGC0000249.1|Nogalamycin_2 	616	1470	-	Loose	500	28.1054	OXA-700	27.27	3005907	protein homolog model	n/a	n/a	carbapenem; cephalosporin; penam	antibiotic inactivation	OXA beta-lactamase	ATGAACCCCGCTCTGCTGGACGACTTCTCCCTGGAGATGACCGGCAAGGACGTGCCCCGGCTGGAGGAGGCGCGCGACGGCATCCCGCCGGGCACCCGGATCAACATCACCTTCCTGGCCGGCGAGGACACCGCCACCCGGCTCACGGCGGCCCGCGCGGTCAAGCGGCTCGGCTTCGTCCCCGTACCGCACATCTCCGCCCGCCGGCTGCCCTCCCGGCCCGCCCTGGAGGAGTTCCTCGCCGGGCTGGCGGCCCACGGCACCGCCGAGAACGTGTTCGTCGTCGGCGGCGACCCCGCCCGGCCCGAGGGCCCCTACGCGGACGCCCTGGCCGTGCTGCGCACCGGGCTGCTGCGCCGCCACGGCGTCCGGCACGTCGGCATCGCCGGCTATCCGGAAGGCCACCCCGGCATCACCGACCGGGCCCTGTGGTCGGCGCTCACGGACAAGGCGGCCGCCATCGACGCGGACCGGTTCGGCGGGGACGTGATCACCCAGTTCGGCTTCGACGCGGACCCGGTCCTCGCCTGGCTGGAGGCCCTGCGCGCCCGGGGCGTGCGCCTGCCCGTCCGGGTCGGCGTCCCCGGACCGGCCGGGGTGCGCCGGCTGCTGGGCTACGCCACCCGGTTCGGCGTCGGCACCAGCGCCTCCGTCGCCCGCAAGTACGGTTTCTCGCTGACCAACCTCATGGGCACCACCGGCCCGGACCGCTTCCTGCACGCGCTGGCCGACCGCTACGACCCCGGCCGGCACGGCGTGGTGAAGGTGCACTTCTACACCTTCGGCGGACTGCGCGCCACCGCCGAGTGGGTCGACGGATTCCGGCGGCAGCACACTCCCGCGCCCGCACCCTGA	MNPALLDDFSLEMTGKDVPRLEEARDGIPPGTRINITFLAGEDTATRLTAARAVKRLGFVPVPHISARRLPSRPALEEFLAGLAAHGTAENVFVVGGDPARPEGPYADALAVLRTGLLRRHGVRHVGIAGYPEGHPGITDRALWSALTDKAAAIDADRFGGDVITQFGFDADPVLAWLEALRARGVRLPVRVGVPGPAGVRRLLGYATRFGVGTSASVARKYGFSLTNLMGTTGPDRFLHALADRYDPGRHGVVKVHFYTFGGLRATAEWVDGFRRQHTPAPAP	MNIKALLLITSAIFISACSPYIVTTNPNHSASKSDEKAEKIKNLFNEAHTTGVLVIQQGQTQQSYGNDLARASTEYVPASTFKMLNALIGLEHHKATTTEVFKWDGKKRLFPEWEKDMTLGDAMKASAIPVYQDLARRIGLELMSKEVKRVGYGNTDIGTQVDNFWLMGPLKITPQQEAQFAYKLANKTLPFSQKVQDEVQSMLFIEEKNGNKIYAKSGWGWDVDPQVGWLTGWVVQPQENIVAFSLNLEMKKGIPSSVRKEITYKSLEQLGIL	103.65	gnl|BL_ORD_ID|3942|hsp_num:0	5012			657	816	cloxacillin; oxacillin; cefalotin
BGC0000249.1|Nogalamycin_3 # 2229 # 2672 # -1 # ID=1_3;partial=00;start_type=GTG;rbs_motif=AGGA;rbs_spacer=5-10bp;gc_cont=0.736	BGC0000249.1|Nogalamycin_3 	2229	2672	-	Loose	270	35.8094	MexR	30.43	3000506	protein overexpression model	n/a	n/a	macrolide antibiotic; fluoroquinolone antibiotic; monobactam; carbapenem; cephalosporin; cephamycin; penam; tetracycline antibiotic; peptide antibiotic; aminocoumarin antibiotic; diaminopyrimidine antibiotic; sulfonamide antibiotic; phenicol antibiotic; penem	antibiotic target alteration; antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	GTGACCGACGACGACACGGAGGTCCCGGGGCTCGTCCGGGAGCTGGTGACCCTCTCCCGGCGCTTTCGGGCCAACGCCGAACGGCTCCACCCCGACCTGAGTTTCGTCGACTATTCACTGCTGTCGGAGCTGGCCGAGCGCGACGGGGCCCGGGCGGGGGAGCTGGTCGGGCTGTACGGGCTGAACAAGTCCACGATCAGCCGCCAGGTCACCGCGCTGGAACGGGCCGGCCTGCTGGTGCGCGAGACCGTCCCCGGAAACCGCCGCGTCCAGCTGCTGCGCCCGAGCGACCGCGGCCGGGAACTGCTCGCCCGCGCCGACGCCCGGATGTACCGCGAGGTCGACGCCCGCACCGCCGGCTGGTCCCCGGAGGAGGTCAGGGCCCTGCGCACCCTGCTGGCCCGCTACAACGCCGCCGCCTCCGCCGTTGCCGGGGACACGTGA	VTDDDTEVPGLVRELVTLSRRFRANAERLHPDLSFVDYSLLSELAERDGARAGELVGLYGLNKSTISRQVTALERAGLLVRETVPGNRRVQLLRPSDRGRELLARADARMYREVDARTAGWSPEEVRALRTLLARYNAAASAVAGDT	MNYPVNPDLMPALMAVFQHVRTRIQSELDCQRLDLTPPDVHVLKLIDEQRGLNLQDLGRQMCRDKALITRKIRELEGRNLVRRERNPSDQRSFQLFLTDEGLAIHQHAEAIMSRVHDELFAPLTPVEQATLVHLLDQCLAAQPLEDI	100.00	gnl|BL_ORD_ID|2333|hsp_num:0	1474			84	423	erythromycin; ciprofloxacin; tetracycline; ceftazidime; ceftriaxone; meropenem; novobiocin; azithromycin; trimethoprim; sulfamethoxazole; chloramphenicol; aztreonam; colistin A; colistin B; ampicillin; panipenem; trimethoprim-sulfamethoxazole
BGC0000249.1|Nogalamycin_4 # 2849 # 3583 # 1 # ID=1_4;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.714	BGC0000249.1|Nogalamycin_4 	2849	3583	+	Loose	600	26.1794	CfxA3	34.55	3003003	protein homolog model	n/a	n/a	cephamycin	antibiotic inactivation	CfxA beta-lactamase	ATGCGAGCCGAGGACGTCGTCCGTGCACCGTCGACACCGCTGGATGCCCCGGCCTTCCCGGCGGGCCCGTACCGGTTCACCGACCGCGAGTACCTGAACATCACCTACCGGACGGACCCCGAGGCCCTGCGCCGGGTGGTGCCGGAGCCGCTGCGGGTGGCGGAGCCGCTGGTCCGCTTCGAGGTCATGCGGATGCCGGACGTCACCGGTCTGGGCGACTACACCGAGGCCGGTCAGCTGGCCGTCGTGGAGTACGAGGGCGAGCCGGGCGAGTACGGCATCTCGATCCACGTGGACAATTTCCCCGCCATCGCGAGCGGCCGGGAGATCGGCGCCTTCCCGAAGAAGGCCGGCCGCCCCCGGCTCTACGTCGACCAGGACACCCTGGTCGGCACCCTCGACCACGGCACGCTGCCCGTGGCCCGCGCCACGATGGGCTACAAGCACCGGCCGCTGAACACGGAGCAGGCCCGCGAGGAGCTGACCCGGCCGACGTTCATGCTCAAGAAGCTGCCGCACTACGACGGTTCGCCGCGCATCTGCGAACTCGTCCGGACGCAGATCGCCGACATCGTGGTCAAGGGCGCCTGGAGCGGTCCCGCACGGCTCCAGCTCTTCGCCCACGCGCTGGCCCCGCTCGCGGACCTGCCGGTCCTGGAGGTCGTCTCCGCCGCCCACGTCCTGACCGATCTGACCCTGGGCCGCGCCCGGGTCGTCCACGACTACCTCGCCTGA	MRAEDVVRAPSTPLDAPAFPAGPYRFTDREYLNITYRTDPEALRRVVPEPLRVAEPLVRFEVMRMPDVTGLGDYTEAGQLAVVEYEGEPGEYGISIHVDNFPAIASGREIGAFPKKAGRPRLYVDQDTLVGTLDHGTLPVARATMGYKHRPLNTEQAREELTRPTFMLKKLPHYDGSPRICELVRTQIADIVVKGAWSGPARLQLFAHALAPLADLPVLEVVSAAHVLTDLTLGRARVVHDYLA	MEKNRKKQIVVLSIALVCIFILVFSLFHKSATKDSANPPLTNVLTDSISQIVSACPGEIGVAVIVNNRDTVKVNNKSVYPMMSVFKVHQALALCNDFDNKGISLDTLVNINRDKLDPKTWSPMLKDYSGPVISLTVRDLLRYTLTQSDNNASNLMFKDMVNVAQTDSFIATLIPRSSFQIAYTEEEMSADHNKAYSNYTSPLGAAMLMNRLFTEGLIDDEKQSFIKNTLKECKTGVDRIAAPLLDKEGVVIAHKTGSGDVNENGVLAAHNDVAYICLPNNISYTLAVFVKDFKGNESQASQYVAHISAVVYSLLMQTSVKS	76.01	gnl|BL_ORD_ID|1750|hsp_num:0	1895			711	876	
BGC0000249.1|Nogalamycin_5 # 3877 # 4422 # -1 # ID=1_5;partial=00;start_type=ATG;rbs_motif=AGGA;rbs_spacer=5-10bp;gc_cont=0.738	BGC0000249.1|Nogalamycin_5 	3877	4422	-	Loose	850	26.9498	opmE	41.82	3003700	protein homolog model	n/a	n/a	macrolide antibiotic; carbapenem; tetracycline antibiotic; diaminopyrimidine antibiotic; phenicol antibiotic; disinfecting agents and antiseptics	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGACCACCATCACCCTCGTCCAGGGCGACATCACCCGGCAGCACGCCGACGCCCTCGTCAACGCGGCCAACTCCTCGCTCCTGGGCGGCGGGGGAGTGGACGGCGCGATCCACCGTCGCGGCGGCCCGGCCATCCTGGCGGAGTGCCGCGCGCTGCGCGCCTCCCGGTACGGCGAGGGCCTGCCCACCGGCCGGGCGGTCGCCACCACGGCGGGTGACCTGGACGCCCGCTGGGTGATCCACACGGTGGGTCCCGTCTGGTCGTCCACCGAGGACCGCTCGGACCTGCTGGCCTCCTGCTACCGCGAGTCCCTGCGCCTGGCAGGCGAACTCGGCGCCCGTACGGTGGCGTTCCCCGCCCTCTCCACCGGCGTCTACCGCTGGCCGATGGGGGACGCGGCCCGCATTGCCGTGGAGACGGTACGCACCACCCCGACCGCCGTCGAGGAGGTCCGTTTCGTCCTCTTCGACACCCACGCGTACGACACGTTCGCCCGGGAACTCGGCGACGCCGGTCACGCCGGTCACGCCGGTCACCCCGGTTGA	MTTITLVQGDITRQHADALVNAANSSLLGGGGVDGAIHRRGGPAILAECRALRASRYGEGLPTGRAVATTAGDLDARWVIHTVGPVWSSTEDRSDLLASCYRESLRLAGELGARTVAFPALSTGVYRWPMGDAARIAVETVRTTPTAVEEVRFVLFDTHAYDTFARELGDAGHAGHAGHPG	MKPYLRSSLSALILLGGCAAVGPDYAPPSASAPASFGAMPAGIDGSGVEIEWWRGFDEPALESLIQRALAANLDIALAGARLDEAKALLRENREEFLPRGGPAFDYQARRRGEVETPAGQQRDIETYRGALDASWEIDLFGRVRRSVEAAEAQAGSREALLRNVQASVAATVAMSWFQLQGIEAELAVVHDIAGNQRDSLEMVERLVSAGSAHEFDRLRAEALLHNVEAAVPDLERRRAATRNALAVLLAEAPQAFSPPVARASGERLTLRTLGVGDPAGLLARRADIAAAERNLAAATARIGVETAGLYPQVEVRGSIGLVAGNLDALDESGTSFNVLNPVIRWALLDRGRVWARIAASEARAQEALILYDRTVLRALQETDDAFNGYGAAADRLRLRLLEATANREAARLARERFVQGDGEYLDVLEAERSDYLSRRALSIARTEQRLAVVGIYKALGGGWEACAGARRCGVATDDTSPGVARQRDSRS	36.86	gnl|BL_ORD_ID|2019|hsp_num:0	2213			294	444	erythromycin; acriflavine; tetracycline; imipenem; trimethoprim; chloramphenicol; thiamphenicol; kitasamycin; rokitamycin
BGC0000249.1|Nogalamycin_6 # 4469 # 5878 # -1 # ID=1_6;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.745	BGC0000249.1|Nogalamycin_6 	4469	5878	-	Loose	1000	33.113	Mycobacterium tuberculosis ethA mutations conferring resistance to prothionamide	30.77	3005106	protein variant model	W69C	W69C:3836, A74S:1935	thioamide antibiotic	antibiotic target alteration	prothionamide resistant ethA	ATGCTCGATGCGGTCGTGGTGGGTGCGGGGCCGAACGGACTGACCGCCGCGGTGGAGCTGGCCCGCCGCGGCTTCTCCGTGGCCCTGTTCGAGGCGAAGTCCACGGTGGGCGGCGGCGCCCGCACGGAGGAGCTGACGCTGCCCGGCTTCCGGCACGACCCGTGCTCGGCCGCGCACCCCCTCGGGGTCAACTCCCCGGCGTTCCGCTCCCTCCCCCTCGACCGGTACGGCCTTGAGTGGCTGCACGCCCCGCTGCCCATGGCCCACCCGTTCCCGGACGGCACCGCGGCCGTGCTGTCCCGTTCGGTGGCCGAGACCGCCGCCTCCTTCGGACCGCGCGACGCGGGCCCGTACCGCAGGCTGGTCGAGCCCCTGCTCGCCCGCTGGGACACCCTGGTCCAGGACTTCATGTCCCTGCCGCTGACCGCGCTGCCCCGCGACCCGGTCACCCTCGCCCGCTTCGGCCTGGCCGGGCTCCCGCCGTCCACCTGGCTGATGCGCCGCTTCAAGGACGAGCGGTTCAAGACCCTCTTCGCCGGCCTCGTCGCCCATGTGATGGCACCGCTGGGCGGCCTCGCCACCAGCGCCGTCGGCCTGGTCTTCGCCCTGTCCGCGCACGCCCGCGGCTGGCCGGTGGCCCGCGGCGGTTCCCAGGCCGTCTCCGACGCCCTCGCCGCGTATCTGAGGGATCTCGGCGGTGCGGTGCACACCGACTTCGAGGTCAAGCGCCTGGACGACCTGCCGCCCGCGCGCGCGTACGTCTTCGACACCTCGCCCGCCGCGCTCGCCCGCATGCCGGCCTCGGCGACTACTACGGCGAACTACCGCTACGGCCCCAGCGTCTTCAAGATCGACTATGCGCTGGACGGCCCGGTGCCGTGGACCGCGCCCGAGGCCCGGAGCGCCGGTACCGTCCAGATCGGCGCGAGCCGGGCCGAGATCGGCACGGCCCTGCGCGCCGCCGCCCGCGAGGGACGCGCACCCGAGCGGCCGTTCATGATCACCGTGCAGCCGAGCGTGGCCGACCCCACCCGGGCCCCCGAGGGCAAGCACGTCTTCTGGGCGTACGGCCATGTGCCGAACGGCTGGACCGGGGACCTCACCGAGGCCATAGAACGCCAGCTGGAGCGCTTCGCCCCCGGCTTCCGCGACCGGGTGCTCGCCCGCGCGACGGCCGGGCCCGCCGAGATGGCCGTCCGCAACGCCAACTACGTCGGCGGGGACATCGCCTGCGGCGCGACCTCCGGACTCCAGCTGCTGCTGCGGCCCAGACTGTCCCTGTTCCCGTACCACACCCCCCACCCGGCCGTCTTCCTCTGCTCCTCGGCCACGCCGCCGGGACCCGGCGTGCACGGCATGTCGGGCCACAATGCGGCCAAGGCGGTCTGGCGGAGACTGAGACAGGGCTGA	MLDAVVVGAGPNGLTAAVELARRGFSVALFEAKSTVGGGARTEELTLPGFRHDPCSAAHPLGVNSPAFRSLPLDRYGLEWLHAPLPMAHPFPDGTAAVLSRSVAETAASFGPRDAGPYRRLVEPLLARWDTLVQDFMSLPLTALPRDPVTLARFGLAGLPPSTWLMRRFKDERFKTLFAGLVAHVMAPLGGLATSAVGLVFALSAHARGWPVARGGSQAVSDALAAYLRDLGGAVHTDFEVKRLDDLPPARAYVFDTSPAALARMPASATTTANYRYGPSVFKIDYALDGPVPWTAPEARSAGTVQIGASRAEIGTALRAAAREGRAPERPFMITVQPSVADPTRAPEGKHVFWAYGHVPNGWTGDLTEAIERQLERFAPGFRDRVLARATAGPAEMAVRNANYVGGDIACGATSGLQLLLRPRLSLFPYHTPHPAVFLCSSATPPGPGVHGMSGHNAAKAVWRRLRQG	MTEHLDVVIVGAGISGVSAAWHLQDRCPTKSYAILEKRESMGGTWDLFRYPGIRSDSDMYTLGFRFRPWTGRQAIADGKPILEYVKSTAAMYGIDRHIRFHHKVISADWSTAENRWTVHIQSHGTLSALTCEFLFLCSGYYNYDEGYSPRFAGSEDFVGPIIHPQHWPEDLDYDAKNIVVIGSGATAVTLVPALADSGAKHVTMLQRSPTYIVSQPDRDGIAEKLNRWLPETMAYTAVRWKNVLRQAAVYSACQKWPRRMRKMFLSLIQRQLPEGYDVRKHFGPHYNPWDQRLCLVPNGDLFRAIRHGKVEVVTDTIERFTATGIRLNSGRELPADIIITATGLNLQLFGGATATIDGQQVDITTTMAYKGMMLSGIPNMAYTVGYTNASWTLKADLVSEFVCRLLNYMDDNGFDTVVVERPGSDVEERPFMEFTPGYVLRSLDELPKQGSRTPWRLNQNYLRDIRLIRRGKIDDEGLRFAKRPAPVGV	95.91	gnl|BL_ORD_ID|2821|hsp_num:0	3837			12	246	prothionamide
BGC0000249.1|Nogalamycin_7 # 5976 # 6830 # -1 # ID=1_7;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.758	BGC0000249.1|Nogalamycin_7 	5976	6830	-	Loose	300	25.409	dfrA3	27.94	3003105	protein homolog model	n/a	n/a	diaminopyrimidine antibiotic	antibiotic target replacement	trimethoprim resistant dihydrofolate reductase dfr	ATGGGAGGCATGATCGAAGAGACGGAAACCATCGAGGAGTTTCTCGCCCGCCGCTCGGCCGACGTGGAGGAGGCGGTCCGCAAGGCCGCCGAGGCCGAGATCCTGCCCCGCTTCCGCCGCCTCGCCGCGCACGAGGTGGACCAGAAGAGCGGCCCGCACGACCTGGTCACGGACGCCGACCGGCTCGCCGAGCTACGGCTCACCGAGGACCTCGGCGCGCTGCTGCCCGGCTCCGTGGTGGTCGGCGAGGAAGCGGTGCACGCCAACCCGGTGGTCTACGAGGCGCTCCAGGGCGACACCCCGGTCTGGATCGTCGACCCGGTCGACGGCACCCGCCAGTTCGTCCACGGCGACGACGGCTTCTGCACCCTGGTGGCCCTCGCCCACCGCGGCACCGTGGTCGCCTCCTGGACCTACGCCGCCGCGCGCGACCGGTTCGCCACCGCCGTCCGCGGCCGGGGCGCCTTCCTCGACGGCGAGCGGCTGTTCGCCGGCCCGCCCGAGCCCGGCCGGGACCTGGTCGTCGCCACCTCCCACCCGGACTACACCACCGACGAGCAGAAGCGCGCGCTGCGCGCCCTGTGGACCGACGGCCTCGCCCCGCGCCCGTGCGGCTCCGCGGGCCTGGAGTACCTCGCGGTCGCCCGGGGCGAGCTGGACGCCGTCGCGTTCTCCTGGGAGGCCGCCTGGGACCACGCGGCCGGACTGCTCCTGGTCGAGGAGGCCGGCGGCACGCACCTCACCCTGACCGGCGAGCCGTTCCGCGTCACCGGCGGCAACGCCCTGCCGTTCACCGCCGCGCGGGACGCCGCCACCGCCCGCCGGGTGGCCGGGCTGCTGCGCACCGCCTCCTGA	MGGMIEETETIEEFLARRSADVEEAVRKAAEAEILPRFRRLAAHEVDQKSGPHDLVTDADRLAELRLTEDLGALLPGSVVVGEEAVHANPVVYEALQGDTPVWIVDPVDGTRQFVHGDDGFCTLVALAHRGTVVASWTYAAARDRFATAVRGRGAFLDGERLFAGPPEPGRDLVVATSHPDYTTDEQKRALRALWTDGLAPRPCGSAGLEYLAVARGELDAVAFSWEAAWDHAAGLLLVEEAGGTHLTLTGEPFRVTGGNALPFTAARDAATARRVAGLLRTAS	MLISLIAALAHNNLIGKDNLIPWHLPADLRHFKAVTLGKPVVMGRRTFESIGRPLPGRRNVVVSRNPQWQAEGVEVAPSLDAALALLTDCEEAMIIGGGQLYAEALPRADRLYLTYIDAQLNGDTHFPDYLSLGWQELERSTHPADDKNSYACEFVTLSRQR	175.31	gnl|BL_ORD_ID|470|hsp_num:0	511			15	216	trimethoprim
BGC0000249.1|Nogalamycin_8 # 7090 # 8955 # -1 # ID=1_8;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.763	BGC0000249.1|Nogalamycin_8 	7090	8955	-	Loose	500	27.7202	ANT(6)-Ia	27.66	3002626	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	ANT(6)	ATGCGGTTCACGACCCGACCCACCCTTCAAGGCACCTTCGGCATGGTCTCCTCCACACACTGGCTGGCCTCCCAGTCGGCGATGGCGGTGCTGGAGGACGGCGGCAACGCCTTCGACGCGGCCGTCGCCGGCGCGTTCGTGCTGCACGTCGTGGAGCCGCATCTGAACGGGCCGGCCGGCGAGGTGCCGATCCTGCTCGCCCCCGCGGGCGGCGCCGTGCGCGTGCTGTGCGGACAGGGCGTCGCCCCGGCCGGCGCCACCCCGGCCCACTACCGGCGCCTCGGGCTGGACCTCGTGCCCGGCACCGGACCGCTCGCCGCCGCCGTGCCCGGCGCCTTCGACGCCTGGCTGCTTTTGCTGCGCGACCACGGCACCAAGCCCCTGGACGCGGTCCTCAAGTACGCCATCGGCTACGCCGAGCACGGGCACGCGCCCGTGGAGAACGTCGGCGCGACCGTGGCGAGCGTACGGCGGCTGTTCGAGACCGAGTGGCCGTCGTCGGCCGAGGTGTACCTGCCCGGCGGCCGGCCGCCCCGGCCCGGGACGCTGCTGCGCAACCCCGCGCTCGCCGCCACCTGGAAGCGGCTGCTGGCCGAGACCGCGGGCGCCGGCGACCGGGAGGCGCGGATCGACGCCGCGCGCGAGGTGTGGCGCTCCGGCTTCATCGCCGAGGCCCTGGTACGGCAGTCCCGGCGGCCCACCATGGACACCAGCGGCGAACGGCACACCGGCACCCTCACCGAGGCCGACCTGGCCGGCTGGTCCGCCCACTACGAGACACCGGTGACGTACGACTGGAACGGCTGGACCGTGTGCAAGGCCGGCCCCTGGAGCCAGGGCCCGGTGCTCCTCCAGCAGCTCGCCCTGCTCCCGGCCGAGCTGCCCGCACCGGGCTCCGCCGACTACGTCCACCTGCTGGTCGAGGGCTGCAAGCTCGCCATGGCCGACCGCGAGGCCTGGTACGGCGACGCCGCCGAGGTGCCCCTCGCCGACCTGCTGTCGGACGCCTACAACGCCGGCCGGCGGGCCCTGATCGGCGCGAAGGCCTCCTACGACCTGCTCCCCGGCAGCCCCGGCGGAAGGCCCCCCAGGCTGCCCGCGCTGGCGCACGCGCGCGTGCCGGCCGACACGCGGCCCGGCTTCGACCCGATGGGCGCCGGGGAGCCGACCGTCGCCCCGCTGCCCGGGGCGCCCACCCTCGCCGAGGCCACCGGTCAGGCGCAGGTGACCGGTGAGGCCGACGTGGCCGCCGACGGCTCGACCCGGGGCGACACCTGCCACCTGGACGTCGTCGACCGCTGGGGCAACATGATCGCGGCCACGCCCAGCGGCGGCTGGCTCCAGTCCAACCCCGTGGTCCCCGAACTCGGCTTCCCGCTCGGCACCCGGCTGCAGATGACCTGGCTGGAGGAGGGCCTGCCGGGCACCCTCACCCCCGGCCGCCGCCCCCGCACCACCCTCACCCCCTCCCTCGCCCTGCGCGACGGGGTACCGGTCCTGGCGTTCGGCACGCCCGGCGGGGACCAGCAGGACCAGTGGCAGCTGCACTTCTTCCTGGCCGCCGCCCTGGGTGCCCCCGTCCGCGGCGGCCTCGACCTCCAGGGCGCCATCGACGCCCCCAACTGGCACAACGACAGCTTCCCCGGCTCCTTCCACCCGCGCCGCCGGCGCCCCGGCAGCGTCACCGTGGAGTCCCGCATGGACCCCGGTGTGATCGAGGAGCTGCGGCGGCGCGGCCACGACGTCACCGTCGGCCCCGCCTGGTCCGAGGGCCGGCTGTGCGCGGTGGCCCGGGACCCGGAGACCGGCATCCTCTCGGCGGCGGCGAACCCGCGCGGGATGCAGGGTTACGCGGTCGGCCGCTGA	MRFTTRPTLQGTFGMVSSTHWLASQSAMAVLEDGGNAFDAAVAGAFVLHVVEPHLNGPAGEVPILLAPAGGAVRVLCGQGVAPAGATPAHYRRLGLDLVPGTGPLAAAVPGAFDAWLLLLRDHGTKPLDAVLKYAIGYAEHGHAPVENVGATVASVRRLFETEWPSSAEVYLPGGRPPRPGTLLRNPALAATWKRLLAETAGAGDREARIDAAREVWRSGFIAEALVRQSRRPTMDTSGERHTGTLTEADLAGWSAHYETPVTYDWNGWTVCKAGPWSQGPVLLQQLALLPAELPAPGSADYVHLLVEGCKLAMADREAWYGDAAEVPLADLLSDAYNAGRRALIGAKASYDLLPGSPGGRPPRLPALAHARVPADTRPGFDPMGAGEPTVAPLPGAPTLAEATGQAQVTGEADVAADGSTRGDTCHLDVVDRWGNMIAATPSGGWLQSNPVVPELGFPLGTRLQMTWLEEGLPGTLTPGRRPRTTLTPSLALRDGVPVLAFGTPGGDQQDQWQLHFFLAAALGAPVRGGLDLQGAIDAPNWHNDSFPGSFHPRRRRPGSVTVESRMDPGVIEELRRRGHDVTVGPAWSEGRLCAVARDPETGILSAAANPRGMQGYAVGR	MRSEKEMMDLVLSLAEQDERIRIVTLEGSRANINIPKDEFQDYDITYFVSDIEPFISNDDWLNQFGNIIMMQKPEDMELFPPEEKGFSYLMLFDDYNKIDLTLLPLEELDNYLKGDKLIKVLIDKDCRIKRDIVPTDIDYHVRKPSAREYDDCCNEFWNVTPYVIKGLCRKEILFAIDHLNQILRFELLRMMSWKVGIKTEFSLSVGKNYKYINKYIDEDLWNRLLSTYRMDSYENIWKSLFICHQLFREVSKEVAELLGFDYPEYGKNITRYTEDMYKKYVENDYF	216.38	gnl|BL_ORD_ID|841|hsp_num:0	914			663	780	streptomycin
BGC0000249.1|Nogalamycin_9 # 9291 # 10127 # 1 # ID=1_9;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.717	BGC0000249.1|Nogalamycin_9 	9291	10127	+	Loose	300	33.8834	Erm(37)	48.65	3000392	protein homolog model	n/a	n/a	macrolide antibiotic; lincosamide antibiotic; streptogramin antibiotic; streptogramin A antibiotic; streptogramin B antibiotic	antibiotic target alteration	Erm 23S ribosomal RNA methyltransferase	ATGACGAACTCCGGGACACGGCCGCAGGAGGTCGCGGACTTCTACGACGGCAGCAGCCGTCTGATCGCCGAACTGAACGGAGGGAGCCTGCACTTCGGCTGCTGGGACTCGCTGCCGGCCGACGCCGGCATGGACCGGGCGTCGCAGCGGCTCACCGAGATGATGACGGAGCGGATCGAGGTCGGCCCCGGACAGCGGGTGCTGGACATCGGCTGCGGCACCGGCGCGCCGGCGGTGCAACTGGCCCGGGCCACCGGCGCCGAGGTCGTGGGCATCACGATCAGCCCGGAGCAGGTCCGGCTGGCCACGGCACACGCCGAGCGGGAGGGAGTCGCCGAGCGGGTCACCTTCCGGTGCGCGGACGCCTCCGCGGAACTCCCCTTCCCCGCCGACTCGTTCGACGCGGTCTGGTTCTTCGAGTCGATCTTCCACCTTCCGGACCGGCTGACCGCGCTGCGCCGGGCGGCCGAGGTCCTGCGGCCGGGCGGGCGACTGGCCCTCACCGACGTCCTGCACAACGACGAAACCTCCCCCGCGGCCCAGGAGTCGCTGGACGAGCACGCGTACACGCCGTTGGTCGGCGAGCCGATGCGGCTGTCCGACTATCCGCCTCTGCTGCGGCAGGCCCGCCTCGTCCCCGTCGAGTGCCGCGACATCAGCGAACTGACCGTGGGGCGCACGCTGGAGTGCATGCACCGCACGCTCGACGAGAACCGCGAGCGCTTCGTCGAGCGGTACGGCAGCGAGCTGGTCGATCAGTTCTCCACGGCCGTCCCGCTCCTGGACGCGGTCGAGTTCGGCTACGGCATCGTCACCGCGGCCCGGCCGGATCACTGA	MTNSGTRPQEVADFYDGSSRLIAELNGGSLHFGCWDSLPADAGMDRASQRLTEMMTERIEVGPGQRVLDIGCGTGAPAVQLARATGAEVVGITISPEQVRLATAHAEREGVAERVTFRCADASAELPFPADSFDAVWFFESIFHLPDRLTALRRAAEVLRPGGRLALTDVLHNDETSPAAQESLDEHAYTPLVGEPMRLSDYPPLLRQARLVPVECRDISELTVGRTLECMHRTLDENRERFVERYGSELVDQFSTAVPLLDAVEFGYGIVTAARPDH	MSALGRSRRAWGWHRLHDEWAARVVSAAAVRPGELVFDIGAGEGALTAHLVRAGARVVAVELHPRRVGVLRERFPGITVVHADAASIRLPGRPFRVVANPPYGISSRLLRTLLAPNSGLVAADLVLQRALVCKFASRNARRFTLTVGLMLPRRAFLPPPHVDSAVLVVRRRKCGDWQGR	155.31	gnl|BL_ORD_ID|421|hsp_num:0	468			93	201	erythromycin; roxithromycin; lincomycin; telithromycin; clarithromycin; clindamycin; tylosin; spiramycin; azithromycin; dirithromycin; pristinamycin IA; quinupristin; virginiamycin M1; madumycin II; griseoviridin; dalfopristin; pristinamycin IB; virginiamycin S2; pristinamycin IC; vernamycin C; patricin A; patricin B; ostreogrycin B3; oleandomycin
BGC0000249.1|Nogalamycin_10 # 10221 # 11042 # 1 # ID=1_10;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.686	BGC0000249.1|Nogalamycin_10 	10221	11042	+	Loose	650	26.1794	TriA	35.71	3003679	protein homolog model	n/a	n/a	disinfecting agents and antiseptics	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGGGGAACACGCCGATCGAGCTCTACCTGGATCTGATGTCACGCACCGTCAGCAACACCATCTACGAGGATCCGCAGATCGACCCGCGCCGCTACTGGGAGCTGCTGCGGGAACGGGACGGCGACGGGACCGGACCGGTCATGGACGGCCCCGGCAATTGGAGTGCCTACGACAGCGAGGGACGCGAGCAGGGCAGCGTCTGGCCGCGCGACGCCCACACCATGGTCGGCATGCGCAGGCTCAGGAACGTACGGGAATGCGCGGAGCGGGTCCTGGCCGACGGGGTGCCGGGCGACTTCATGGAGACCGGCGTGTGGCGCGGCGGCACCTGCATCTTCATGCGGGCGGTGCTGGCGGCGTACGAGGTCAGCGACCGCGTGGTGTGGGTCGCCGACTCCTTCGCCGGTATCCCCGCGCCCGACCTGGACCGCTATCCGCAGGACGAGGAGGCGCGGGGCATCGAGTCGGTCAACGAGGTGGTGGGCGTGCCCCTGGAGACCGTCCGCGGCAACTTCGACCGCTACGGGCTGCTCGACGACCAGGTGCGGTTCCTCCCGGGACGGTTCTGCGACACGCTGCCCGAGGCCCCCGTGGAGCGGCTGGCGCTGCTGCGTCTGGACGGGGATCTGTACGAATCCACGATGGACGCCCTGGTGTCGATGTACCCGAAGCTGTCGCCCGGCGGCTATCTGATCGTGGACGACTACCACGCCCTGGACGTCTGCAAGAAGGCCGTGCACGACTATCGGGACCAGCACGGCATCGACGACCCGATCACGGACATCGACTGGTCGGGGGCCTACTGGCGCAAGAGCGCCTGA	MGNTPIELYLDLMSRTVSNTIYEDPQIDPRRYWELLRERDGDGTGPVMDGPGNWSAYDSEGREQGSVWPRDAHTMVGMRRLRNVRECAERVLADGVPGDFMETGVWRGGTCIFMRAVLAAYEVSDRVVWVADSFAGIPAPDLDRYPQDEEARGIESVNEVVGVPLETVRGNFDRYGLLDDQVRFLPGRFCDTLPEAPVERLALLRLDGDLYESTMDALVSMYPKLSPGGYLIVDDYHALDVCKKAVHDYRDQHGIDDPITDIDWSGAYWRKSA	MSDARGAFHSKGRWSRMALPAILCAGLLVGCGAEPPAEEHVRVLAQTVKMAEFASATSITGDIQARVQADQSFRVGGKIVERLVDVGDHVAAGQVLARLDPQDQRSNVENAQAAVAAQQAQSKLADLNYQRQKALLPKGYTSQSEYDQALASVRSAQSSLKAAQAQLANARDLLSYTELRASDAGVITARQAEVGQVVQATVPIFTLARDGERDAVFNVYESLFSHDVDGQRITVSLLGKPEVTASGKVREITPTVDERSGTLKVKVGLDSVPAEMSLGSVVNASVAAPAEHSVVLPWSALSKVGEQPAVWLLDQQGKARLQPVRVARYASEKVVIDGGLEAGQTVVTVGGQLLHPGQVVEVAQPPQPTQSTASRDAVGGGQP	71.28	gnl|BL_ORD_ID|2002|hsp_num:0	2192			891	1014	triclosan
BGC0000249.1|Nogalamycin_11 # 11110 # 12324 # -1 # ID=1_11;partial=00;start_type=TTG;rbs_motif=AGGA;rbs_spacer=5-10bp;gc_cont=0.709	BGC0000249.1|Nogalamycin_11 	11110	12324	-	Loose	700	31.9574	DHA-18	24.82	3002149	protein homolog model	n/a	n/a	cephalosporin; cephamycin	antibiotic inactivation	DHA beta-lactamase	TTGACCCTCCATCAGACCGGCCCGGCGGCCCCGCGGCCGGACTCCTCCACCACACCCCCTCTGTCGCCGGAGACCGCGGACCTGCTCGCCGAACTCGGTGGCTACCTGGTCCCGGACCCGCCCGCCCTCAGCCTGCCGCCCCGGGCGTTCGCCTCCGGTGAGCTGTACGAGCTGGAGCGGGAGAAGGTCTTCGGCCGTTCCTGGCTTCTCGTCGCGCACACCGACCAACTCGCCGGCCCCGGTGCCTACGTCGCCCTCACCGTCGCGGGCGAACCCGTCGTCATCACGCGCGGCGACGACGGCGCGCTGCACGCGATGTCACCGATCTGCCGCCACCGCATGATGCCGGTCGTCGAACCGGGCACCGGCCGCACCGACCGGTTCACCTGCCCGTACCACCTGTGGCGCTACGGACTGGACGGCCGGTTGATCGGCGCCACCTTCATGCGGCGCAACGAGGCGTTCGACCCCGCCGGCTGCCGACTGCCGCAGTTCGCCGTGGAAGAGTGGCACGGGTTCGTCTTCGTCAACCTCGACCCCGCGGCGGAAGCCCTGGCTCCGCACCTCGCCCGAATCGAAAGCGACCTGGTCAACTACCGCCTGGACGACATGGTACTGGCCGGGGAATGGGCCGAGGAGTGGCACTGCAACTGGAAGATCGCCGTGGAGAACGCGCACGAGAACTACCACGTGATGGGCTTCCACCCCGAGACCCTGGAACCGTCCACCCCGGGCCGCTCCGACACGGATCTGCGCGACGACACGCCGTGGGCGCTGCGTTTCCGCATCCCGTTCACCGAGCCCCAGCAGCCGTCCCTCCTCTCCCTGACCGAGGACGAGAAGGCTCACCTGTACGACTTCTTCGTCTTCCCCACCGGGAGCCTCGCCGCCGCCGGGGAGGCGGTGATCTGGCTGAGCATGCTCCCGTTGTCCCTCGACCGCACCCAGGTCCGCGGGGGCATGCTGGTCCCCGCCGCCCGGGTCAAGGACCTCGGTGAGGCCGAACGGAAGGAGATGCGGCAGGGCATCGAGTCGTACTCCGCGATGGTCAACGCGGAGGACCGGCGCGGCCTGGAGGCCGTGCAGCGGTCCGTGGGCTCCCGGTTCGCCGCGCGCGGCCACCTCAGCCCCAAGGAGCCGGCCGTCGTCTCCTTCTACCGGAACCTGGCGCGCGCCCTGCTGCGTGGCGACGACGAGTGGCCCGGCGCCCTCTGA	MTLHQTGPAAPRPDSSTTPPLSPETADLLAELGGYLVPDPPALSLPPRAFASGELYELEREKVFGRSWLLVAHTDQLAGPGAYVALTVAGEPVVITRGDDGALHAMSPICRHRMMPVVEPGTGRTDRFTCPYHLWRYGLDGRLIGATFMRRNEAFDPAGCRLPQFAVEEWHGFVFVNLDPAAEALAPHLARIESDLVNYRLDDMVLAGEWAEEWHCNWKIAVENAHENYHVMGFHPETLEPSTPGRSDTDLRDDTPWALRFRIPFTEPQQPSLLSLTEDEKAHLYDFFVFPTGSLAAAGEAVIWLSMLPLSLDRTQVRGGMLVPAARVKDLGEAERKEMRQGIESYSAMVNAEDRRGLEAVQRSVGSRFAARGHLSPKEPAVVSFYRNLARALLRGDDEWPGAL	MKKSLSATLISALLAFSAPGFSAADNVAAVVDSTIKPLMAQQDIPGMAVAVSVKGKPYYFNYGFADVQAKQPVTENTLFELGSVSKTFTGVLGAVSVAKKETALNDPAAKYQPELALPQWKGITLLDLATYTAGGLPLQVPDAVKSRADLLNFYQQWQPSWKPGDMRLYANSSIGLFGALTANAAGMPYEQLLTARILAPLGLSHTFITVPESVQSRYAYGYKNKKPVRVSPGQLDAESYGVKSASKDMLRWAEMNMEPSRAGNADLEMAMYLAQTRYYKTAAINQGLGWEMYDWPQQKDMIINGVTNEVALQPHPVTDNQVQPYNRASWVHKTGATTGFGAYVAFIPEKQVAIVILANKNYPNTERVKAAQAILSALE	106.60	gnl|BL_ORD_ID|1357|hsp_num:0	1472			132	486	
BGC0000249.1|Nogalamycin_12 # 12321 # 12635 # -1 # ID=1_12;partial=01;start_type=Edge;rbs_motif=None;rbs_spacer=None;gc_cont=0.733	BGC0000249.1|Nogalamycin_12 	12321	12635	-	Loose	450	26.5646	CGB-1	27.59	3000841	protein homolog model	n/a	n/a	carbapenem; cephalosporin; penam	antibiotic inactivation	CGB beta-lactamase	ATCTGGATGCCGCGGGTCACGGTGCCACTGCGGGCCGGCGACTGCACCTTCCACCACGCCCGCACCGTGCACAGCGCCGGGGCGAACTCGACCGACGAGCCCCGCTTGTCGACCTCCGCCGTCTACATGGACGCCACCGCCGCCTACCGGCCGACCGGCATCGCGTTTCTCGACGACCTCCCCGGCACCGGAGCCGACCCGCTGCGCGAGGGCGCCCCCCTCACCGGCGACCGCTTCCCCCTGCTGCGCCGACCGCAGACCCGACAGCCCGCCCCCGCCCGGTATCCCCTTCCACAGCAAGGACACGGATCTTGA	IWMPRVTVPLRAGDCTFHHARTVHSAGANSTDEPRLSTSAVYMDATAAYRPTGIAFLDDLPGTGADPLREGAPLTGDRFPLLRRPQTRQPAPARYPLPQQGHGS	MKKSIPFFIISMLLSPLANAQDTQVRDFVIEPQIQPNFYIYKTFGVFGGKEYSTNAVYLVTKKGVVLFDVPWQKTQYQSLMDTIQKRHHLPVIAVFATHSHEDRAGDLSFYNKKGIKTYATAKTNEILKKEGKATSTEIIKTGKPYRIGGEEFVVDFLGEGHTADNVVVWFPKYKILDGGCLVKSKAAADLGYTGEANVAQWPKTMEKLKSKYAQATLIIPGHDEWKGGGHVEHTLDLLNKK	42.98	gnl|BL_ORD_ID|903|hsp_num:0	871			309	483	
